|
|
Article: Pharmaceutical company launches Axid Oral Solution.
- Article from:
- Obesity, Fitness & Wellness Week
- Article date:
- August 28, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 AUG 28 - (NewsRx.com & NewsRx.net) -- Reliant Pharmaceuticals, Inc., announced the introduction and the availability of Axid (nizatidine) Oral Solution, a liquid formulation of the company's Axid capsules.
Approved by the U.S. Food and Drug Administration in May of this year, Axid Oral Solution is indicated for use in pediatric patients age 12 and older for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to gastroesophageal reflux disease (GERD) for up to 12 weeks. In adults, Axid Oral Solution is also approved for the treatment of active duodenal ulcers. Ernest Mario, PhD, ...